Loading
companiesCompany
Oncobox
Oncobox profiles a tumour's genes and the activity of its signalling pathways, then ranks approved targeted drugs by how likely they are to work for that patient.
Overview
Oncobox Dx combines tumour DNA and RNA sequencing with pathway-activation algorithms to score more than a hundred marketed targeted drugs for an individual patient with advanced cancer, returning a ranked report for the treating oncologist. Its YC profile cites a European and Asian study of about 900 late-stage patients in which the approach was associated with higher targeted-therapy effectiveness; that work is observational and the test has not been validated in a randomised trial. Oncobox remains active in the YC directory and markets to clinicians, hospitals and pharma.
Headquarters
Walnut, CA, US
Funding
All startupsStartupYC S17
Investors
Type
Stage
Startup · Y Combinator Summer 2017
Website
Similar pages
- CompanyData Driven Bioscience (Duoseq)
Shares Y Combinator, RNA sequencing & expression profiling, Comprehensive genomic profiling and the tag yc.
- CompanyCambridge Cancer Genomics (CCG.ai)
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyBlank Bio
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
- CompanyYemaachi Biotech
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyOmanta
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyIsabl
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
- CompanyBillionToOne
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.